CVS Health Corp (CVS)

Management unveils a plan to split the company into two public businesses.

Diversified healthcare company CVS Health (NYSE:CVS) reported revenue ahead of Wall Street’s expectations in Q3 2026, with revenue up 5.4% year on year to $1...

Diversified healthcare company CVS Health (NYSE:CVS) will be reporting results this Wednesday before market open. Here’s what you need to know. CVS Health be...

Alphabet's 12% drop followed search and YouTube misses as Google Cloud beat. Altimetry likes Microsoft, AMD and Generac and avoids CoreWeave and Cipher Digital.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

CVS Health stock is down 16% from its 52-week high, and it trades at a relatively modest valuation.

Treasuries pay more today, but these three healthcare dividend payers offer something Treasuries can't: growth in both the payout and the stock.

Income investors now have a choice they haven't had to make in nearly two decades.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance provi...

CVS Health is looking more attractive -- and it sports an appealing dividend, too, recently yielding 2.8%.

CVS Health (NYSE:CVS) executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on healthcare cost trends and several 2027 headwinds. Speaking at an investor conference, Chief Financial Of

The stock is down about 13% from its 52-week high.

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Cencora (NYSE:COR) and its pe...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be...

Wall Street is warming to the prospects of the healthcare giant.

The healthcare giant's shares have pulled back more than 12% over the past month.

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how health insurance provi...